We have discussed CANNABIX TECHNOLOG (OTCMKTS:BLOZF) and its potentially game changing Marijuana Breathalyzer technology in the past. One of the biggest concerns in places where marijuana is legal in some form, is the belief that it impairs driving ability. While that may or may not be true depending on the person in question, many jurisdictions would be champing at the bit for a working cannabis breath test.
It seems that the day they have been waiting for is approaching quickly, with the company having just reported
CANNABIX TECHNOLOG (OTCMKTS:BLOZF) announced that development of its “Beta 3.0” (Cannabix Marijuana Breathalyzer) prototype device based on its FAIMS- (field asymmetric waveform ion mobility spectrometry) has been proceeding at a robust pace and is now complete. This device is designed to operate both independently or coupled in tandem directly to a conventional Quadrupole Mass Spectrometer (MS) device used in forensic labs.
The Beta 3.0 prototype incorporates several key technological improvements which include enhancements to the ion source which, for portability, has been reduced in size with sustained stability, providing improvements to transmission and overall device sensitivity. The Beta 3.0 prototype also incorporates its own tunable self-contained detector which can be used in both independent FAIMS operation or in “pass-through” mode for tandem coupling directly with a MS device.
Chief Scientific Officer, Dr. Raj Attariwala, states, “With completion of the modular Beta 3.0 prototype, Cannabix has achieved several key developmental milestones allowing this technology to be directly tested against the accepted laboratory standard of mass spectrometry”.
The Company has performed preliminary bench testing with the Beta 3.0 prototype and has successfully detected THC using the device in stand-alone mode with tandem MS analysis demonstrating direct correlation. This is a significant developmental milestone which the Company will use to optimize and characterize the device’s performance measures both independently and coupled to MS.
Cannabix has been on the leading edge in innovation with FAIMS technology built upon the current technique of MS for measuring THC. MS is considered the gold standard in toxicology in the analysis of drugs, poisons, and metabolites, due to its superior specificity and sensitivity. It is anticipated that any marijuana breathalyzer product will need to have its results be secondarily confirmed by independent MS. Recent work by Company scientists and engineers to allow the Cannabix Marijuana breathalyzer to easily couple to conventional MS equipment used in toxicology labs everywhere is a significant achievement. (Source: Globe Newswire)
While marijuana is nowhere near alcohol in terms of how dangerous it is to consume and then get behind the wheel, the ability for instant on site detection could be useful not just for law enforcement, but for other government agencies as well as private employers. The market is certainly there, and we’ve been waiting for BLOZF to move on from the developmental stage for quite a long time. It remains to be seen when that will actually occur, so we will want to stay on top of anything new coming from BLOZF.
If Cannabix can indeed field a working marijuana breathalyzer device, it could mean big business opportunities, not only in places where marijuana is legal, but just about everywhere else as well. It’s a story that we are most interesting in tracking on an ongoing basis. Keep it locked to Street Register for updates, and we’ll deliver those important developments on BLOZF to you as they unfold. In the meantime, if you’ve yet to sign up for our 100% free newsletter, do so now! Just enter your active email address into the box below and submit!
Disclosure: No one at Street Register has been compensated in any way for the publishing of this article, nor do we hold any position in BLOZF stock, short or long.